Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-15
2005-02-15
Kunz, Gary (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C424S400000, C424S439000, C424S464000, C424S451000, C536S001110, C514S002600, C514S023000, C514S773000, C514S777000
Reexamination Certificate
active
06855727
ABSTRACT:
An antifatigue composition for reducing muscular fatigue or the like during or after exercise, which includes an imidazole compound obtained from extracts of fishes, shelifishes, fowl, flesh or the like, as an active ingredient. The imidazole compound in the antifatigue composition is preferably at least one compound selected from the group consisting of histidine, anserine, carnosine, valenine and salts thereof. The antifatigue composition preferably further contains D-ribose as an active ingredient. By orally ingesting the antifatigue composition, the amount of lactic acid in plasma during or after exercise can be kept low, and therefore muscle fatigue caused by exercise can be controlled, and as a result, the ability to exercise can be improved.
REFERENCES:
patent: 4028184 (1977-06-01), Ishiyama et al.
patent: 5391550 (1995-02-01), Carniglia et al.
patent: 5397786 (1995-03-01), Simone
patent: 5965596 (1999-10-01), Harris et al.
patent: 6159942 (2000-12-01), St. Cyr et al.
patent: 6420342 (2002-07-01), Hageman et al.
patent: 324227 (1989-07-01), None
patent: 0449787 (1991-02-01), None
patent: 0652012 (1993-11-01), None
patent: 0652012 (1995-05-01), None
patent: 0 710 485 (1996-05-01), None
patent: 873754 (1998-10-01), None
patent: 0 894 439 (1999-02-01), None
patent: 983726 (2000-03-01), None
patent: 58-165774 (1983-09-01), None
patent: 59-210871 (1984-11-01), None
patent: 60-094075 (1985-05-01), None
patent: 61181357 (1986-08-01), None
patent: 07-025838 (1995-01-01), None
patent: 08-198748 (1996-08-01), None
patent: 09020660 (1997-01-01), None
patent: 9-020661 (1997-01-01), None
patent: 09-249556 (1997-09-01), None
patent: 2000-026290 (2000-01-01), None
patent: WO 9006102 (1990-06-01), None
patent: WO 9806278 (1998-02-01), None
patent: WO 9965476 (1999-12-01), None
patent: WO 0185178 (2001-11-01), None
Bralley J.A. and Lord R.S., “Treatment of Chronic Fatigue Syndrome with Specific Amino Acid Supplementation”,Journal of Applied Nutrition, vol. 46, No. 3, (1994), pp. 74-78.
R.C. Harris et al, “Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation”,Clinical Science, 83, pp. 367-374, (1992).
M. Suyama et al, “Chromatographic Determination of Imidazole Compounds in the Whale Meat”,Bulletin of the Japanese Society of Scientific Fisheries, vol. 33, No. 2, pp. 141-146, (1967).
Kikuchi Kazuaki
Matahira Yoshiharu
Frishauf Holtz Goodman & Chick P.C.
Gollamudi Sharmila S
Kunz Gary
Yaizu Suisankagaku Industry Co. Ltd.
LandOfFree
Muscular fatigue-controlling composition and method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscular fatigue-controlling composition and method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscular fatigue-controlling composition and method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3464338